Bell Centre to be Equipped with the Noveko(TM) Antimicrobial Filtration
Technology - Durable, economical and eco-friendly filters

EKO / TSX

MONTREAL, June 28 /CNW Telbec/ - Noveko International Inc. ("the Company") is pleased to announce that its subsidiary Noveko Inc. has entered into an agreement to equip the entire Bell Centre, a multi-purpose building recognized as the most outstanding entertainment venue in Montreal, with filters incorporating the Noveko(TM) antimicrobial filtration technology. This six-year agreement covers the supply of the filters and their cleaning. The parties have agreed to keep the financial terms and conditions of this agreement confidential.

Located in downtown Montreal and having a 21,273-seat capacity, the Bell Centre is the largest hockey arena in North America and the home of the legendary Montreal Canadiens Hockey Club. The Bell Centre is also one of the most technologically advanced and versatile venues worldwide. More than 1.5 million spectators attend the hockey games and some 120 shows staged there each year.

An Ideal Solution for a Sustainable Development Strategy

"We once again demonstrated we offer an ideal solution for any sustainable building project. After being used for over a year at the Bell Centre, our filters' degree of effectiveness and durability proved to be unmatched and beyond all expectations in a quite complex technical environment. We are particularly proud to team up with the Bell Centre, which is not only the Tricolore's general headquarters, but also the internationally renowned scene of large-scale events and shows on the cutting edge of technology. This new breakthrough in a high-potential market attests to the keen interest in our filtration solutions and sets the stage for us to equip many other multi-purpose sports and cultural arenas and amphitheatres. We are confident that the marketing of our filters in the buildings segment will accelerate over the next fiscal year," indicated Mr. Simon Labrecque, Vice-President, Filtration of Noveko Inc.

"The ventilation systems at the Bell Centre are subjected to quite difficult conditions. We were impressed with the filters' resistance to variations in temperature and humidity, as well as their useful life. Even after a lengthy testing period, they did not need any cleaning and had retained their filtration capacity. The use of Noveko(TM) filtration solutions results in a lower energy bill and less filtration waste, which makes us particularly proud now that we have obtained our LEED, silver, ISO 14001 et ICI ON RECYCLE level 3 certifications. We are also pleased to provide our clients with a solution that is not only more effective and eco-friendly but also healthier, thanks to its innovative patented antimicrobial features," added Mr Xavier Luydlin, Director of operations, Bell Centre.

Noveko(TM) Antimicrobial Filter Features

Filters incorporating the Noveko(TM) antimicrobial filtration technology consist of four layers of synthetic fibre that are fully leak-proof and offer an excellent resistance to temperature variations. Their superior filtration effectiveness also enables users to achieve ventilation systems related energy savings. Thanks to their greater durability and the fact that they are entirely washable and recyclable, the number of filters and the costs associated with their replacement are reduced considerably, making them a first-class environmental solution.

Profile

Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, mainly air filters, surgical masks and respirators, as well as other products with antibacterial properties such as hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to account for new information, new events or new circumstances.

For further information: Chantal Vennat, Director, Investor Relations and Corporate Communications, Noveko International Inc., Tel: [phone], http://www.noveko.com; Media: Mathieu Beaudoin, Morin Relations Publiques, Tel.: [phone] extension 225